Amesite (NASDAQ:AMST – Get Free Report) and Definitive Healthcare (NASDAQ:DH – Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.
Profitability
This table compares Amesite and Definitive Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Amesite | -1,024.91% | -118.33% | -103.03% |
| Definitive Healthcare | -76.04% | 4.04% | 1.99% |
Analyst Ratings
This is a breakdown of current ratings for Amesite and Definitive Healthcare, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Amesite | 1 | 0 | 0 | 0 | 1.00 |
| Definitive Healthcare | 3 | 3 | 1 | 1 | 2.00 |
Valuation & Earnings
This table compares Amesite and Definitive Healthcare”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Amesite | $110,000.00 | 34.23 | -$3.62 million | ($0.64) | -1.29 |
| Definitive Healthcare | $238.26 million | 0.36 | -$138.93 million | ($1.62) | -0.50 |
Amesite has higher earnings, but lower revenue than Definitive Healthcare. Amesite is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Amesite has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Definitive Healthcare has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500.
Insider & Institutional Ownership
3.6% of Amesite shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 36.0% of Amesite shares are held by insiders. Comparatively, 16.3% of Definitive Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Definitive Healthcare beats Amesite on 11 of the 15 factors compared between the two stocks.
About Amesite
Amesite Inc., an artificial intelligence driven platform and course designer, that provides online products in the United States. The company uses machine learning to offer a mass customized experience to learners. It serves businesses, universities and colleges, K-12 schools, museums, and non-profit organizations. Amesite Inc. was incorporated in 2017 and is headquartered in Detroit, Michigan.
About Definitive Healthcare
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Receive News & Ratings for Amesite Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amesite and related companies with MarketBeat.com's FREE daily email newsletter.
